Abstract:Polyglucosan storage disorders represent an emerging field within neurodegenerative and neuromuscular conditions. We combined molecular genetic analyses, quantitative mass spectrometry of laser micro‐dissected polyglucosan bodies, immunohistochemistry and western blot, and show that the absence of glycogenin‐1 (GYG1), a protein important for glycogen synthesis initiation, causes storage of polyglucosan that displays accumulation of several proteins, including those essential for glycogen synthesis, sequestosome 1/p62 and desmin. Aims Polyglucosan storage disorders represent an emerging field within neurodegenerative and neuromuscular conditions, including Lafora disease (EPM2A, EPM2B), adult polyglucosan body disease (APBD, GBE1), polyglucosan body myopathies associated with RBCK1 deficiency (PGBM1, RBCK1) or glycogenin‐1 deficiency (PGBM2, GYG1). While the storage material primarily comprises glycans, this study aimed to gain deeper insights into the protein components by proteomic profiling of the storage material in glycogenin‐1 deficiency. Methods We employed molecular genetic analyses, quantitative mass spectrometry of laser micro‐dissected polyglucosan bodies and muscle homogenate, immunohistochemistry and western blot analyses in muscle tissue from a 45‐year‐old patient with proximal muscle weakness from late teenage years due to polyglucosan storage myopathy. Results The muscle tissue exhibited a complete absence of glycogenin‐1 due to a novel homozygous deep intronic variant in GYG1 (c.7+992T>G), introducing a pseudo‐exon causing frameshift and a premature stop codon. Accumulated proteins in the polyglucosan bodies constituted components of glycogen metabolism, protein quality control pathways and desmin. Muscle fibres containing polyglucosan bodies frequently exhibited depletion of normal glycogen. Conclusions The absence of glycogenin‐1, a protein important for glycogen synthesis initiation, causes storage of polyglucosan that displays accumulation of several proteins, including those essential for glycogen synthesis, sequestosome 1/p62 and desmin, mirroring findings in RBCK1 deficiency. These results suggest shared pathogenic pathways across different diseases exhibiting polyglucosan storage. Such insights have implications for therapy in these rare yet devastating and presently untreatable disorders.

Mutations in hereditary phosphoglucomutase 1 deficiency map to key regions of enzyme structure and function

Conformation and Dynamics of the C-terminal Region in Human Phosphoglycerate Mutase 1

A missense variant remote from the active site impairs stability of human phosphoglucomutase 1

Clinical and Molecular Genetic Characterization of Two Patients with Mutations in the Phosphoglucomutase 1 (PGM1) Gene

Congenital Disorder of Glycosylation Type 1T with a Novel Truncated Homozygous Mutation in PGM1 Gene and Literature Review.

The X-ray Crystal Structures of Human Α-Phosphomannomutase 1 Reveal the Structural Basis of Congenital Disorder of Glycosylation Type 1A

Molecular mechanisms of catalytic inhibition for active site mutations in glucose-6-phosphatase catalytic subunit 1 linked to glycogen storage disease

Destabilization and Degradation of a Disease-Linked PGM1 Protein Variant

Expression analysis revealing destabilizing mutations in phosphomannomutase 2 deficiency (PMM2-CDG): expression analysis of PMM2-CDG mutations

Sumoylation-deficient phosphoglycerate mutase 2 impairs myogenic differentiation

Long-range structural defects by pathogenic mutations in most severe glucose-6-phosphate dehydrogenase deficiency

GMPPB-congenital Disorders of Glycosylation Associate with Decreased Enzymatic Activity of GMPPB

Case report: Comprehensive exploration of a novel PFKM mutation in glycogen storage disease Type VII

Consequences of GMPPB deficiency for neuromuscular development and maintenance

The novel compound heterozygous variants identified in a Chinese family with glucose phosphate isomerase deficiency and pathogenicity analysis

Molecular Genetics of Type 1 Glycogen Storage Disease

Clinical and Molecular Spectrum of Glucose-6-Phosphate Isomerase Deficiency. Report of 12 New Cases

Proteomic profiling of polyglucosan bodies associated with glycogenin‐1 deficiency in skeletal muscle

Activities of Glycogen Synthetase and UDPG-pyrophosphorylase in Muscle of a Patient with a New Type of Muscle Glycogenosis caused by Phosphofructokinase Deficiency

Purification and detailed study of two clinically different human glucose 6-phosphate dehydrogenase variants, G6PD(Plymouth) and G6PD(Mahidol): Evidence for defective protein folding as the basis of disease

Cysteine Mutations Impair the Structural Stability of Phosphomannomutase 2 (PMM2) in Glycosylation-Associated Metabolic Disorders